ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
IMMUNOTHERAPY OF PROSTATE-CANCER IN THE DUNNING RAT MODEL - USE OF CYTOKINE GENE MODIFIED TUMOR VACCINES
Author(s): VIEWEG J, ROSENTHAL FM, BANNERJI R, HESTON WDW, FAIR WR, GANSBACHER B, GILBOA E
Source: CANCER RESEARCH    Volume: 54    Issue: 7    Pages: 1760-1765    Published: APR 1 1994  
Times Cited: 190     References: 34     
Abstract: Adenocarcinoma of the prostate is the most common cancer in men. The majority of cancers are discovered once they have already metastasized, and there is no effective therapy for prostatic cancer at this stage. The use of cytokine-secreting tumor cell preparations as therapeutic vaccines for the treatment of advanced prostate cancer was investigated in the Dunning rat R3327-MatLyLu prostatic tumor model. IL-2 secreting, irradiated, tumor cell preparations were capable of curing animals with s.c. established tumors, and induced immunological memory that protected animals from subsequent tumor challenge. Immunotherapy was less effective when tumors were induced orthotopically, but nevertheless led to improved outcome, significantly delaying, and occasionally preventing, recurrence of tumors after resection of the cancerous prostate. Granulocyte-macrophage colony stimulating factor secreting tumor cell preparations were less effective, and interferon-gamma secreting cells had only a marginal effect. Induction of a potent immune response in tumor bearing animals against the nonimmunogenic MatLyLu tumor supports the view that active immunotherapy warrants further investigation as a potential therapeutic approach to prostate cancer.
Document Type: Article
Language: English
Addresses:
1. MEM SLOAN KETTERING CANC CTR, DEPT SURG, DIV HEMATOL ONCOL, NEW YORK, NY 10021 USA
2. MEM SLOAN KETTERING CANC CTR, UROL SERV, NEW YORK, NY 10021 USA
3. MEM SLOAN KETTERING CANC CTR, MOLEC BIOL PROGRAM, NEW YORK, NY 10021 USA
Publisher: AMER ASSOC CANCER RESEARCH, PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W., PHILADELPHIA, PA 19106
Subject Category: Oncology
IDS Number: ND238
ISSN: 0008-5472
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo